Muscle Weakness Completed Phase 3 Trials for Sugammadex (DB06206)

Also known as: Weakness, Muscle / Muscle Weakness | Patient / Muscle Weakness / Patient / Motor weakness / Paresis / Weakness muscle / Muscular weakness / Muscle weakness NOS

IndicationStatusPhase
DBCOND0002242 (Muscle Weakness)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01962298Recovery of Diaphragmatic Function After Neuromuscular Blockade and SugammadexTreatment